You don’t spend almost 30 years as the undisputed expert in long-term cryostorage without gathering a treasure trove of information on the subject. In our extensive bank of articles, blogs, and FAQ’s, you’ll find everything you would want to know about fertility preservation and long-term cryostorage.

Please take a moment to search our blog and articles for any information you may need. If you can’t find it there, your questions may be answered in our FAQ section. In the event that you can’t find what you’re looking for there, please get in touch with us. We’re here to help!

FAQs – How does the reversal of Roe Vs. Wade affect reproductive tissue storage?

How will the reversal of Roe vs. Wade impact the storage of my embryos at ReproTech? For clients with embryos in storage at all ReproTech locations, currently there is no impact to the storage of your embryos. You have the same control over storing, transferring, donating (when applicable) or discarding your embryos. What if my embryos are stored in your Texas location? Based on ASRM’s guidance in their Potential Implications for Reproductive Medicine report, ReproTech currently does not expect any impact in the operations at any of our locations, including ReproTech Texas. According to the ASRM report, Texas's Human Life [Read More...]

ReproTech Appoints Brad Senstra as Chief Executive Officer

ReproTech, the industry leader in human reproductive tissue cryogenic storage, has appointed Brad Senstra as Chief Executive Officer. Mr. Senstra brings to ReproTech more than 16 years of experience in fertility and reproductive medicine. Before accepting this position, he served as Executive Director of Seattle Reproductive Medicine (“SRM”). Mr. Senstra is a noted thought leader in reproductive medicine and has presented at numerous American Society for Reproductive Medicine meetings and events over the past 16 years. He also served on the Association of Reproductive Managers Board from 2014-2017. Mr. Senstra earned his Master's of Health Administration from the University of [Read More...]

Cancer Patients Require Improved Education About Fertility Preservation Options

We at ReproTech are aware of the need for improved access to preserving fertility before cancer treatment and have long partnered with oncologists nationwide to provide an avenue of affordable and safe cryostorage for their patients’ reproductive specimens. Research shows that patients facing fertility-threatening treatments and thus at risk for infertility must be educated about the chances early in treatment planning. UPMC-Magee’s study, published in March 2023, is one of many studies showing a critical need for improved access to fertility preservation for all who want to have a future family following disease recovery.

FAQ: Transferring and storing your reproductive specimens with ReproTech – oocytes, embryos, sperm, ovarian/testicular tissues

ReproTech specializes in long-term cryostorage of human reproductive tissues (embryos, oocytes, semen, testicular/ovarian tissues). Here we answer commonly asked questions about shipping and storing these tissues with ReproTech.

Twins born from 30-yr-old embryos sets new record

We specialize in the cryostorage of human reproductive tissues. You may wonder how long an embryo can be frozen and remain viable after so many years. How are embryos frozen, and do they result in a pregnancy as often as a fresh embryo? And last, how does ReproTech fit into the family-building journey? We’re here to give you a quick overview!

ReproTech Medical Advisory Committee Member Dr. Kyle E. Orwig, Ph.D. Awarded ASRM’s 2022 Distinguished Researcher Award

The American Society for Reproductive Medicine (ASRM) announced its 2022 awards. We are excited to see that a ReproTech’s Medical Advisory Committee member, Kyle Orwig, Ph.D., will be the recipient of the ASRM Distinguished Researcher Award! This award is given for "outstanding contributions to clinical or basic research in reproduction published during the previous ten years.” Dr. Orwig oversees the UPMC Fertility Preservation Program and the UPMC Magee Center for Reproduction and Transplantation. UPMC's fertility preservation program freezes testicular and ovarian tissue for children and adults before beginning fertility-threatening treatments, or for transgender individuals, before beginning gender-affirming hormone therapy. One area [Read More...]

ReproTech Responds to the Dobbs Decision that reverses Roe vs. Wade

On June 24, 2022, the Supreme Court overturned federal protections for abortion in the Dobbs vs. Jackson decision that reversed Roe vs. Wade. We expect this will also affect reproductive medicine and long-term reproductive cryostorage in the coming months and years. ReproTech continues to work with our legal advisors to determine how this ruling and subsequent personhood laws will impact our cryostorage services as state “trigger” laws go into effect and new laws are written. We are closely monitoring the guidance of the American Society for Reproductive Medicine (ASRM) and the American Association of Tissue Banks (AATB). We currently do [Read More...]

‘Science News’ Cites Study Involving ReproTech Experts

March 4, 2022 - Science News follows up 50 years later on a 1972 report about the viability of sperm after freezing. In February 1972 Science News reported that men banking their sperm were doing so without knowing how long their specimens would be viable for. They recently provided a 50-year update to this report, citing a study from 2013 in which an almost 40-yr-old, donated sperm specimen was used in the conception of healthy twin girls to a same-sex couple. The cited study involved ReproTech's own CEO Brent Hazelrigg and founder Russ Bierbaum. Long-term cryostorage continues to be a [Read More...]

What happens if you have a reactive infectious disease result?

ReproTech maintains multi-step safety procedures to eliminate potential cross-contamination between reactive and non-reactive embryos, semen, testicular tissue, oocytes (eggs) and ovarian tissue. From the clinic, to the maintenance of the specimens at ReproTech, these extra steps allow for the safety of reproductive tissue storage for all patients. After a patient establishes an account with ReproTech, we will request serology test results for communicable diseases such as HIV, Hepatitis B, Hepatitis C, Syphilis, or SARS-CoV-2/COVID-19. If a test shows a reactive result, ReproTech will send a shipping container for transport that is dedicated for potentially infectious specimens. When the specimens reach [Read More...]

  • 1
  • 2
  • 5